|Text of Recommendation|| |
As OIG has previously recommended, CMS should work directly with hospices to ensure that they are providing drugs covered under the hospice benefit and CMS should develop and execute a strategy to ensure that Part D does not pay for drugs that should be covered by the Part A hospice benefit.
|Recommendation Number|| |
|Recommendation Status|| |
|Significant Recommendation|| |
|Recommendation Questioned Costs|| |
|Recommendation Funds for Better Use|| |